Nutraveris
Friday, September 22, 2017

Fenugreek for reducing menopausal symptoms: a double-blinded, randomized and placebo-controlled clinical trial.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The purpose of this double-blinded, randomized and placebo-controlled trial was to examine the effects of Trigonella foenum-graecum on menopausal symptoms. 115 women with menopausal symptoms (peri- and post-menopause), aged 40 to 65 years, have been enrolled.

59 of them were allocated to the active treatment, i.e. 600 mg per day of a T. foenum-graecum de-husked seed extract (Libifem®, dry concentrate 33:1, equivalent to 19.8 g dry herb, standardized to a minimum of 50% of furostanol saponins), for 12 weeks.

 

Fenugreek

 

Results showed that the supplementation reduction menopausal symptoms, as highlighted by the total Menopause-specific Quality Of Life score (p < 0.001 in comparison to placebo). The four subscores have been also improved by the supplementation (vasomotor, psychosocial, physical, and sexual symptoms, p < 0.001 for all vs. placebo). Reduction in daytime hot flushes and night sweats at 12 weeks have been also reported (p < 0.001). Interestingly, serum estradiol levels have not been affected by the supplementation.

 

Therefore, the tested fenugreek extract can reduce menopausal symptoms in healthy peri- and post-menopausal women.

 

Steels E, Steele ML, Harold M, Coulson S. Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study. Phytother Res. 2017 Jul 14.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Wednesday, September 20, 2017

Omega 3 fatty acids supplementation improves premenstrual symptoms in women.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

A multi-center, balanced (1:1), placebo-controlled, parallel-group randomized clinical trial investigated whether omega-3 supplement improved premenstrual symptoms and health-related quality of life among 95 reproductive aged women suffering from premenstrual symptoms (aged 20-35 years). The treatment consisted of omega-3 supplement containing 1 g fish oil or a placebo (free of oil).

Most premenstrual symptoms and their interference with daily activities were significantly reduced over the follow-up period (table). The longer use of omega-3 supplement provides improvement of premenstrual symptoms and activities.

 

 

Comparison of mean score of symptoms and intensity of complaints according to the PSST identified in omega-3 and placebo groups before and during the first, second and third month after the intervention.

Comparison of mean score of symptoms and intensity of complaints according to the PSST identified in omega-3 and placebo groups before and during the first, second and third month after the intervention.

 

 

The treatment of premenstrual symptoms using omega-3 fatty acids supplement reduced symptoms.

 

 

Behboudi-Gandevani S, Hariri FZ, Moghaddam-Banaem L. The effect of omega 3 fatty acid supplementation on premenstrual syndrome and health-related quality of life: a randomized clinical trial. J Psychosom Obstet Gynaecol. 2017 Jul 14:1-7.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, September 14, 2017

Whey protein are source for sport men which wish to increase their muscle mass. Since few years scientific data have tried to demonstrate the implication of whey proteins during the post-effort recovery.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The recovery phase is the most important stage of the exercise to prevent injury and increase the performance for the next training session or competition.

Whey protein

The present study aims to identify if whey protein ingestion enhances whole body net protein balance or recovery of exercise performance during over-night (post-10h) and 24h recovery after whole body resistance exercise. To do so, a double blind crossover study has been performed in 12 trained men (76±8 kg aged 24±4 years). The volunteers performed resistance exercise in the evening prior to consuming either 25 g of whey protein or an energy-matched placebo immediately post-exercise. They consumed again the following morning. A third randomized trial, completed by the same participants, involving no exercise and no supplement served as rested control trial.

The ingestion of [15N]glycine allowed to determine whole body protein kinetics and net protein balance over time of recovery.

The authors highlighted a tendency to improve the net balance protein in whey protein group (p=0.064) during over-night recovery. Over the 24h, net balance was enhanced in the same group (p=0.0036) but not in the placebo group. The authors suggested this difference is mediated by a reduction in protein breakdown (p<0.01).

 

This study points out whey protein supplementation enhances whole body anabolism, and may improve acute recovery of exercise performance after a strenuous bout of resistance exercise.

 

West DWD, Abou Sawan S, Mazzulla M, Williamson E, Moore DR, Whey protein supplementation enhances whole body protein metabolism and performance recovery after resistance exercise: a double-blind crossover study. (2017) Nutrients 9 (7) pii E735

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, September 12, 2017

Helicobacter pylori infection commonly occurred during the childhood and leads to major intestinal disorders which may be dangerous for the child health. This infection has been recently classified as carcinogen by the World Health Organization (WHO).

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10 years by more than 500 industry leaders informs you:

 

Eradiction of Helicobacter pylori in children is an important issue for the different health organization notably the WHO.

 

Helicobacter pylori

 

The present study aims to identify the best probiotic supplementation in triple therapy for pediatric population with Helicobacter pylori. To do so, 29 eligible trials were identified (3122 participants) involving 17 probiotic regimens. Each randomized, double-blinded placebo-controlled study was analyzed. Compared with placebo, probiotic-supplemented triple therapy significantly increased Helicobacter pylori (Relative ration, 1.19 95% CI 1.13-1.25).

To supplemented triple therapy, Lactobacillus casei was identified as the best to eradicate the bacteria (P score = 0.84). Furthermore a multi-strain of Lactobacillus acidophilus and Lactobacillus rhamnosus was effective too.

Finally, the authors highlighted a multi-strains of Bifidobacterium infantis, Bifidobacterium longum, L. acidophilus, L. casei, Lactobacillus plantarum, Lactobacillus reuteri, L. rhamnosus, Lactobacillus salivarius, Lactobacillus sporogenes, and Streptococcus thermophilus was the best to reduce the incidence of diarrhea but not for reducing nausea.

 

This study points out that probiotics are recommended to supplement triple therapy in pediatrics. Note that the effectiveness of triple therapy is associated with specific probiotic supplementation.

 

 

Feng JR, Wang F, Qiu X, McFarland L, Chen P, Zhou R, Liu J, Zhzao Q, Li J, Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children : a systematic review and network meta-analysis (2017) Eur J Clin Pharmacol (in press)

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, September 7, 2017

Training regulation on 14 November in Paris

The fundamentals of the European regulation

and its development:

Food supplements and health ingredients

Tuesday, November 14, 2017, in Paris

 

Inscription here

 

 

Full program here

 

 

Page 1/10412345...102030...Last »